SpyGlass
Device SpyGlass_ENDO
PDI 08714729764441
General payments
$447,119
Research payments
$23,718
Through program year 2025, $447,119 in general payments and $23,718 in research payments were reported against SpyGlass (SpyGlass_ENDO).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $145,246 | 1,199 |
| 2024 | General | $42,763 | 463 |
| 2024 | Research | $23,718 | 7 |
| 2023 | General | $68,486 | 963 |
| 2022 | General | $172,754 | 1,661 |
| 2021 | General | $17,870 | 19 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,305 general · 7 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.